Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
Ophthalmology
|
August 27, 2014
A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study
Mark C Gillies, Lyndell L Lim, Anna Campain, et al.
Journal of Medicinal Chemistry
|
August 6, 1993
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996)
I Sircar, J C Hodges, J Quin, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
Derivatives of 5-[[1-(4'-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists
J J Edmunds, S Klutchko, J M Hamby, et al.
Journal of Medicinal Chemistry
|
January 1, 1992
Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors
A M Doherty, I Sircar, B E Kornberg, et al.
Journal of Medicinal Chemistry
|
November 1, 1991
Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype
C J Blankley, J C Hodges, S R Klutchko, et al.
Ophthalmology. Retina
|
April 25, 2019
Development of New Proliferative Diabetic Retinopathy in the BEVORDEX Trial
Hemal Mehta, Lyndell L Lim, Vuong Nguyen, et al.
BMC Medicine
|
August 22, 2021
Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic
Terence J Quin, Jennifer K Burton, Ben Carter, et al.
Journal of Medicinal Chemistry
|
October 28, 1997
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice
D J McNamara, E Dobrusin, D M Leonard, et al.
Human Mutation
|
March 24, 2009
Planning the human variome project: the Spain report
Jim Kaput, Richard G H Cotton, Lauren Hardman, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
Ophthalmology
|
August 27, 2014
A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study
Mark C Gillies, Lyndell L Lim, Anna Campain, et al.
Journal of Medicinal Chemistry
|
August 6, 1993
Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996)
I Sircar, J C Hodges, J Quin, et al.
Journal of Medicinal Chemistry
|
September 15, 1995
Derivatives of 5-[[1-(4'-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists
J J Edmunds, S Klutchko, J M Hamby, et al.
Journal of Medicinal Chemistry
|
January 1, 1992
Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors
A M Doherty, I Sircar, B E Kornberg, et al.
Journal of Medicinal Chemistry
|
November 1, 1991
Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype
C J Blankley, J C Hodges, S R Klutchko, et al.
Ophthalmology. Retina
|
April 25, 2019
Development of New Proliferative Diabetic Retinopathy in the BEVORDEX Trial
Hemal Mehta, Lyndell L Lim, Vuong Nguyen, et al.
BMC Medicine
|
August 22, 2021
Correction to: Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic
Terence J Quin, Jennifer K Burton, Ben Carter, et al.
Journal of Medicinal Chemistry
|
October 28, 1997
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in mice
D J McNamara, E Dobrusin, D M Leonard, et al.
Human Mutation
|
March 24, 2009
Planning the human variome project: the Spain report
Jim Kaput, Richard G H Cotton, Lauren Hardman, et al.
Page
of 5